p73 haploinsufficiency causes tau hyperphosphorylation and tau kinase dysregulation in mouse models of aging and Alzheimer's disease

被引:23
|
作者
Cancino, Gonzalo I. [1 ,2 ]
Miller, Freda D. [2 ,3 ,4 ]
Kaplan, David R. [1 ,3 ]
机构
[1] Hosp Sick Children, Cell Biol Program, Toronto, ON M5G 1L7, Canada
[2] Hosp Sick Children, Program Dev & Stem Cell Biol, Toronto, ON M5G 1L7, Canada
[3] Univ Toronto, Dept Mol Genet, Toronto, ON, Canada
[4] Univ Toronto, Dept Physiol, Toronto, ON, Canada
关键词
p73; p53; family; Tau phosphorylation; Pin1; Alzheimer's disease; Aging; Neurodegeneration; GSK-3; beta; c-Abl; Cdk5; Tauopathy; Paired helical filaments; TgCRND8; PROLYL ISOMERASE PIN1; C-ABL; NEURONAL SURVIVAL; P53; FAMILY; PHOSPHORYLATION; CDK5; MAINTENANCE; PATHOLOGY; BRAIN; MICE;
D O I
10.1016/j.neurobiolaging.2012.04.010
中图分类号
R592 [老年病学]; C [社会科学总论];
学科分类号
03 ; 0303 ; 100203 ;
摘要
Haploinsufficiency for the p53 family member p73 causes behavioral and neuroanatomical correlates of neurodegeneration in aging mice, including the appearance of aberrant phospho-tau-positive aggregates. Here, we show that these aggregates and tau hyperphosphorylation, as well as a generalized dysregulation of the tau kinases GSK3 beta, c-Abl, and Cdk5, occur in the brains of aged p73+/- mice. To investigate whether p73 haploinsufficiency therefore represents a general risk factor for tau hyperphosphorylation during neurodegeneration, we crossed the p73+/- mice with 2 mouse models of neurodegeneration, TgCRND8+/empty set mice that express human mutant amyloid precursor protein, and Pin1-/- mice. We show that haploinsufficiency for p73 leads to the early appearance of phospho-tau-positive aggregates, tau hyperphosphorylation, and activation of GSK3 beta, c-Abl, and Cdk5 in the brains of both of these mouse models. Moreover, p73+/-; TgCRND8+/empty set mice display a shortened lifespan relative to TgCRND8+/empty set mice that are wild type for p73. Thus, p73 is required to protect the murine brain from tau hyperphosphorylation during aging and degeneration. (C) 2013 Elsevier Inc. All rights reserved.
引用
收藏
页码:387 / 399
页数:13
相关论文
共 50 条
  • [41] Tau expression in transgenic mouse models of amyotrophic lateral sclerosis and Alzheimer's disease
    Kuzma, M.
    Kazmierczak, B.
    Usarek, E.
    Gajewska, B.
    Muench, C.
    Ludolph, A. C.
    Baranczyk-Kuzma, A.
    JOURNAL OF NEUROLOGY, 2006, 253 : 121 - 121
  • [42] Brain metabolism in tau and amyloid mouse models of Alzheimer's disease: An MRI study
    Wei, Zhiliang
    Xu, Jiadi
    Chen, Lin
    Hirschler, Lydiane
    Barbier, Emmanuel L.
    Li, Tong
    Wong, Philip C.
    Lu, Hanzhang
    NMR IN BIOMEDICINE, 2021, 34 (09)
  • [43] S100β interaction with tau is promoted by zinc and inhibited by hyperphosphorylation in Alzheimer's disease
    Yu, WH
    Fraser, PE
    JOURNAL OF NEUROSCIENCE, 2001, 21 (07): : 2240 - 2246
  • [44] The Ambiguous Relationship of Oxidative Stress, Tau Hyperphosphorylation, and Autophagy Dysfunction in Alzheimer's Disease
    Liu, Zhenzhen
    Li, Tao
    Li, Ping
    Wei, Nannan
    Zhao, Zhiquan
    Liang, Huimin
    Ji, Xinying
    Chen, Wenwu
    Xue, Mengzhou
    Wei, Jianshe
    OXIDATIVE MEDICINE AND CELLULAR LONGEVITY, 2015, 2015
  • [45] The Link Between Diabetes Mellitus and Tau Hyperphosphorylation: Implications for Risk of Alzheimer's Disease
    Hobday, Amy L.
    Parmar, Mayur S.
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2021, 13 (09)
  • [46] Tau transgenic mouse models and their relevance to progressive supranuclear palsy and Alzheimer's disease
    Lewis, J
    MOVEMENT DISORDERS, 2002, 17 (06) : 1404 - 1404
  • [47] Fibroblast growth factor 10 ameliorates neurodegeneration in mouse and cellular models of Alzheimer's disease via reducing tau hyperphosphorylation and neuronal apoptosis
    Guo, Kaiming
    Huang, Wenting
    Chen, Kun
    Huang, Pengkai
    Peng, Wenshuo
    Shi, Ruiqing
    He, Tao
    Zhang, Mulan
    Wang, Hao
    Hu, Jian
    Wang, Xinshi
    Shentu, Yangping
    Xu, Huiqin
    Lin, Li
    AGING CELL, 2023, 22 (09)
  • [48] CSF p-tau205: a biomarker of tau pathology in Alzheimer’s disease
    Juan Lantero-Rodriguez
    Laia Montoliu-Gaya
    Andrea L. Benedet
    Agathe Vrillon
    Julien Dumurgier
    Emmanuel Cognat
    Wagner S. Brum
    Nesrine Rahmouni
    Jenna Stevenson
    Stijn Servaes
    Joseph Therriault
    Bruno Becker
    Gunnar Brinkmalm
    Anniina Snellman
    Hanna Huber
    Hlin Kvartsberg
    Nicholas J. Ashton
    Henrik Zetterberg
    Claire Paquet
    Pedro Rosa-Neto
    Kaj Blennow
    Acta Neuropathologica, 2024, 147
  • [49] CSF p-tau205: a biomarker of tau pathology in Alzheimer's disease
    Lantero-Rodriguez, Juan
    Montoliu-Gaya, Laia
    Benedet, Andrea L.
    Vrillon, Agathe
    Dumurgier, Julien
    Cognat, Emmanuel
    Brum, Wagner S.
    Rahmouni, Nesrine
    Stevenson, Jenna
    Servaes, Stijn
    Therriault, Joseph
    Becker, Bruno
    Brinkmalm, Gunnar
    Snellman, Anniina
    Huber, Hanna
    Kvartsberg, Hlin
    Ashton, Nicholas J.
    Zetterberg, Henrik
    Paquet, Claire
    Rosa-Neto, Pedro
    Blennow, Kaj
    ACTA NEUROPATHOLOGICA, 2024, 147 (01)
  • [50] Rac1 activation links tau hyperphosphorylation and Aβ dysmetabolism in Alzheimer's disease
    Borin, Mirta
    Saraceno, Claudia
    Catania, Marcella
    Lorenzetto, Erika
    Pontelli, Valeria
    Paterlini, Anna
    Fostinelli, Silvia
    Avesani, Anna
    Di Fede, Giuseppe
    Zanusso, Gianluigi
    Benussi, Luisa
    Binetti, Giuliano
    Zorzan, Simone
    Ghidoni, Roberta
    Buffelli, Mario
    Bolognin, Silvia
    ACTA NEUROPATHOLOGICA COMMUNICATIONS, 2018, 6